August 22, 2017 9:09 AM ET

Healthcare Providers and Services

Company Overview of Genoptix, Inc.

Company Overview

Genoptix, Inc. provides specialized oncology diagnostics services. It offers a range of customizable clinical trial services, custom assay development, and companion diagnostics development services. The company’s services include chromogenic and fluorescent immunohistochemistry and phospho-immunohistochemistry as single-color or multiplexed assays; cytogenetics and flow cytometry; and a range of molecular testing platforms. The company also performs specialty assays on oncology specimens to support patient diagnosis and stratification for trial to determine pharmacodynamic status, or to assess disease prognosis and monitor its progression; and designs and optimizes custom assays specific to...

1811 Aston Avenue

Carlsbad, CA 92008

United States

Founded in 1999

508 Employees

Phone:

760-268-6200

Fax:

760-268-6201

Key Executives for Genoptix, Inc.

Chief Executive Officer
Age: 64
Chief Financial Officer
President of Cartesian Medical Group and Chief Medical Officer of Cartesian Medical Group
Age: 58
Chief Technical Officer and Senior Vice President of Business Development & Medical Affairs
Age: 62
Chief Information Officer and Senior Vice President
Age: 54
Compensation as of Fiscal Year 2017.

Genoptix, Inc. Key Developments

Genoptix, Inc. and Bionano Genomics, Inc. Announce Strategic Alliance

Genoptix, Inc. and Bionano Genomics®, Inc. announced an exclusive agreement to co-develop information-rich diagnostics for selected hematologic oncology indications in the US using Bionano’s Saphyr™ System. Bionano’s Saphyr System accurately visualizes the structure of a genome from a simple DNA sample isolated directly from cancer cells, removing the need for cell culture. It allows for the detection of all major types of structural variants with a sensitivity far greater than sequencing based methods, and with much higher resolution than karyotyping or fluorescence in situ hybridization (FISH) can provide. The development efforts of Genoptix and Bionano will focus on indications within hematology-oncology where detection of large structural variations of the genome is required for accurate diagnosis. Cancer cells typically show a large number of major rearrangements of the genome, and their presence or absence can affect the characteristics of the tumor and its response to treatment and, therefore, direct clinical care.

Genoptix, Inc. Announces Management Appointments

Ampersand Capital Partners and 1315 Capital, has completed the acquisition of Genoptix, Inc. from Novartis. Joseph M. Limber, who previously served as CEO of Prometheus Laboratories, will lead the new Genoptix as Chief Executive Officer. He will be joined by Mark Spring as Chief Financial Officer and Juan Estruch as Head of Corporate Development, both of whom served with Limber on the executive team at Prometheus Laboratories.

Genoptix, Inc. Announces Executive Appointments

In partnership with Ampersand Capital Partners and 1315 Capital, has entered into a definitive agreement to acquire the commercial laboratory of Genoptix, Inc. This transaction is expected to close in the first quarter of 2017 subject to certain closing conditions. Joseph M. Limber, who previously served as CEO of Prometheus Laboratories, will become CEO of Genoptix upon completion of the transaction. Mark Spring, who served as CFO of Prometheus, will serve as CFO of Genoptix. Under Mr. Limber's leadership, Prometheus became a leading commercial U.S. specialty diagnostic and therapeutic company in gastroenterology and oncology, with an innovative oncology diagnostic platform, culminating in its successful sale to Nestle Health Sciences in 2011.

Similar Private Companies By Industry

Company Name Region
@ Home Medical, Inc. United States
@home approach, llc United States
@Home Care United States
1011 E. Pecan Grove Road, LLC United States
1104 Welsh Road Operations LLC United States

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
January 30, 2017
--
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
The Advertising Council, Inc. United States
Bertelsmann AG Europe
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Genoptix, Inc., please visit www.genoptix.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.